Gilead Sciences pharmaceutical company is seen in Oceanside, California, on April 29, 2020 after they announced a Phase 3 Trial of the investigational antiviral drug remdesivir in patients with severe coronavirus disease (COVID-19).

Gilead Sciences pharmaceutical business is seen in Oceanside, California, on April 29, 2020 after they revealed a Stage 3 Trial of the investigational antiviral drug remdesivir in patients with serious coronavirus disease (COVID-19).|Photo Credit:
REUTERS.

.

.

Drug has nod for emergency situation use

Remdesivir shows ‘precise’ effect in treating COVID-19

They sign up with Hetero Labs, Jubilant Lifesciences and Mylan, who had actually signed the arrangement last month with Gilead.

An investigational antiviral treatment, remdesivir has receiv